Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Phio Pharmaceuticals

    Client Virtual Booth

    PHIO PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Phio Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    257 Simarano Dr Marlborough, Massachusetts 01752
    Telephone
    Telephone
    508-929-3634
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://phiopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/phio-pharmaceuticals-corp/
    Twitter
    Twitter
    https://twitter.com/phio_pharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Phio Announces Closing of $4 Million Concurrent Registered Direct Offering
    Phio Announces Closing of $4 Million Concurrent Registered Direct Offering

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-closing-of-4-million-concurrent-registered-direct-offering-and-private-placement-priced-at-the-market-under-nasdaq-rules-301841467.html

    PR NEWSWIRE
    02 Jun 2023
    Share Share
    Phio Announces $4 Million Concurrent Registered Direct Offering
    Phio Announces $4 Million Concurrent Registered Direct Offering

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-4-million-concurrent-registered-direct-offering-and-private-placement-priced-at-the-market-under-nasdaq-rules-301838146.html

    PR NEWSWIRE
    31 May 2023
    Share Share
    Phio Pharma Announces Initiation of Collaborative Clinical Trial with PH-762
    Phio Pharma Announces Initiation of Collaborative Clinical Trial with PH-762

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-initiation-of-collaborative-clinical-trial-with-ph-762-agonoxs-tumor-infiltrating-lymphocyte-program-agx148-and-providence-cancer-institute-301832848.html

    PR NEWSWIRE
    24 May 2023
    Share Share
    Phio Presents Study Showing INTASYL™ Treatment of NK Cells
    Phio Presents Study Showing INTASYL™ Treatment of NK Cells

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-presents-preclinical-study-showing-intasyl-treatment-of-nk-cells-more-than-doubles-ability-to-kill-tumor-cells-301828708.html

    PR NEWSWIRE
    18 May 2023
    Share Share
    Phio Pharmaceuticals receives FDA IND clearance for PH-762 trial
    Phio Pharmaceuticals receives FDA IND clearance for PH-762 trial

    https://www.clinicaltrialsarena.com/news/phio-pharmaceuticals-fda-ph-762/

    CLINICAL TRIALS ARENA
    17 May 2023
    Share Share
    Phio Pharma Announces FDA Clearance to Initiate Clinical Trial of PH-762
    Phio Pharma Announces FDA Clearance to Initiate Clinical Trial of PH-762

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-fda-clearance-to-initiate-clinical-trial-of-ph-762-for-treatment-of-skin-carcinomas-301825168.html

    PR NEWSWIRE
    16 May 2023
    Share Share
    Phio Pharmaceuticals Reports 1Q 2023FYR &Provides Business Update
    Phio Pharmaceuticals Reports 1Q 2023FYR &Provides Business Update

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-reports-first-quarter-2023-financial-results-and-provides-business-update-301822643.html

    PR NEWSWIRE
    11 May 2023
    Share Share
    Phio Pharmaceuticals Announces $2 Million Registered Direct Offering
    Phio Pharmaceuticals Announces $2 Million Registered Direct Offering

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-2-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-301800695.html

    PR NEWSWIRE
    18 Apr 2023
    Share Share
    Phio Pharma Presents Preclinical Data Demons Synergy Efficacy of PD-1/CTLA-4
    Phio Pharma Presents Preclinical Data Demons Synergy Efficacy of PD-1/CTLA-4

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-presents-preclinical-data-demonstrating-synergy-enhanced-in-vivo-anti-tumor-efficacy-of-pd-1ctla-4-dual-targeting-intasyl-301799637.html

    PR NEWSWIRE
    18 Apr 2023
    Share Share
    Phio Pharmaceuticals Presents Preclinical Study Showing PH-762 Induces
    Phio Pharmaceuticals Presents Preclinical Study Showing PH-762 Induces

    https://www.prnewswire.com/news-releases/phio-pharmaceuticals-presents-preclinical-study-showing-ph-762-induces-systemic-memory-t-cell-mediators-of-anti-tumor-immunity-301798049.html

    PR NEWSWIRE
    17 Apr 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search